美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Global Partners Lp

53.11

+0.11000.21%

成交量：2.62万

成交额：139.06万

市值：18.06亿

市盈率：20.42

高：53.25

开：52.99

低：52.26

收：53.00

52周最高：60.00

52周最低：40.66

股本：3,399.56万

流通股本：2,767.42万

量比：0.37

换手率：0.09%

股息：2.97

股息率：5.59%

每股收益(TTM):2.60

每股收益(LYR):2.45

净资产收益率：16.33%

总资产收益率：4.09%

市净率：2.96

市盈率(LYR):21.71

数据加载中...

总览公司新闻公告

歌礼制药-B(01672)将在第61届欧洲糖尿病研究协会(EASD)年会上报告ASC30 口服小分子GLP-1R激动剂28天多剂量递增研究结果

大行评级｜里昂：上调阿里健康目标价至6.5港元维持“跑赢大市”评级

减重赛道全球前沿进展跟踪(二)：ORFORGLIPRON领跑全球小分子GLP-1RA赛道国内管线价值逐渐凸显

司美格鲁肽最新临床数据出炉！GLP-1战火延伸至心血管赛道

21世纪经济报道

在GLP-1（胰高血糖素样肽-1）减肥药的竞争中诺和诺德的司美格鲁肽终于凭借心血管方面的获益扳回一局。9月1日记者从诺和

礼来终止2项口服GLP-1药二期试验

生物药大时代

礼来口服GLP-1药物orforglipron III期研究成功

谁在网购减重版GLP-1？京东健康：90后购买量排第一，未来电商渠道预计超过七成

映恩生物上半年调整后利润1.46亿元，现金37.47亿元；礼来口服GLP-1一项3期临床成功

Ofweek维科网

Viking Therapeutics股价下跌3.8%竞争对手礼来的GLP - 1药片在糖尿病患者后期研究中助力减轻体重

礼来公司（Eli Lilly）在晚期试验中发现其GLP - 1片剂使2型糖尿病患者体重减轻10.5%该公司股价上涨3.2

礼来公布口服GLP-1RA III期临床结果，肥胖适应症预计今年在美提交

礼来公司周二表示其每日服用的减肥药丸在后期试验中帮助肥胖和2型糖尿病患者减轻了体重达到了研究的主要目标为该公司在全球范围

浙商证券：看好国内细分领域布局药企出海BD机遇关注GLP-1多靶点国内一梯队BD进展

信达生物小分子GLP-1R激动剂获批临床|亚盛医药Bcl-2抑制剂欧美获批全球注册3期临床|荣昌生物再破局

中国医药创新促...

信达生物小分子GLP-1R激动剂在中国获批临床

贝莱德的 Levy-Odom 将领导美洲地区的监管工作

贝莱德的 Levy-Odom 将领导美洲地区的监管工作

研报掘金丨开源证券：华东医药创新药收入快速增长，维持“买入”评级

总数跌破70万家，零售药店上演“鱿鱼游戏”！有门店下场做药妆、开卖GLP-1减肥药

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/GLP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners Lp","latestPrice":53.11,"timestamp":1756497600000,"preClose":53,"halted":0,"volume":26235,"delay":0,"floatShares":27674174,"shares":33995563,"eps":2.600398,"marketStatus":"盘前交易","change":0.11,"latestTime":"09-02 07:38:30 EDT","open":52.99,"high":53.25,"low":52.2584,"amount":1390617.921424,"amplitude":0.018709,"askPrice":58.61,"askSize":100,"bidPrice":53.11,"bidSize":18,"shortable":3,"etf":0,"ttmEps":2.600398,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756819800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":53.11,"dividendRate":0.055922,"postHourTrading":{"tag":"盘后","latestPrice":53.11,"preClose":53.11,"latestTime":"16:10 EDT","volume":458,"amount":24324.38,"timestamp":1756498204619},"volumeRatio":0.37201895674344926,"impliedVol":0.238,"impliedVolPercentile":0.1968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27674174,"roa":"4.09%","roe":"16.33%","lyrEps":2.44604,"volumeRatio":0.37201895674344926,"shares":33995563,"dividePrice":2.97,"high":53.25,"amplitude":0.018709,"preClose":53,"low":52.2584,"week52Low":40.66,"pbRate":"2.96","psRate":"0.10","week52High":60,"institutionHeld":0.4647,"latestPrice":53.11,"committee":-0.694915,"eps":2.600398,"divideRate":0.055922,"volume":26235,"delay":0,"ttmEps":2.600398,"open":52.99,"prevYearClose":46.55,"prevWeekClose":53.11,"prevMonthClose":53.11,"prevQuarterClose":52.73,"fiveDayClose":50.97,"twentyDayClose":51.58,"sixtyDayClose":52.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"date":"2025-08-08","symbol":"GLP","amount":0.75,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-08","defaultRemindTime":1754659800000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-08-08","currency":"USD","dateTimestamp":1754625600000,"payDate":"2025-08-14"},{"market":"US","date":"2025-08-07","symbol":"GLP","fiscalQuarterEnding":"2025/06","expectedEps":0.6,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.55},{"date":"2025-05-09","symbol":"GLP","amount":0.745,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-05-15"},{"market":"US","date":"2025-05-08","symbol":"GLP","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":0.36},{"market":"US","date":"2025-02-28","symbol":"GLP","fiscalQuarterEnding":"2024/12","expectedEps":0.24,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2015-11-02","recordDate":"2015-11-04","paymentDate":"2015-11-13","value":0.6975,"currency":"USD"},{"executeDate":"2016-02-08","recordDate":"2016-02-10","paymentDate":"2016-02-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-08-04","recordDate":"2016-08-08","paymentDate":"2016-08-12","value":0.4625,"currency":"USD"},{"executeDate":"2016-11-04","recordDate":"2016-11-08","paymentDate":"2016-11-14","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741233600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2025-08-29","current":18.669318,"percent":0.886838,"low":2.771386,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"high":29.34912,"avg":10.924102,"sd":6.358204,"marketCap":1796753795},"quantilePoints":[{"date":"2020-09-04","current":4.542915,"twenty":6.2824,"median":8.213544,"eighty":11.285346,"marketCap":420437682},{"date":"2020-09-11","current":4.749076,"twenty":6.27606,"median":8.174338,"eighty":11.274368,"marketCap":439517512},{"date":"2020-09-18","current":4.815342,"twenty":6.275736,"median":8.086126,"eighty":11.269162,"marketCap":445650315},{"date":"2020-09-25","current":4.73435,"twenty":6.258044,"median":8.00583,"eighty":11.265698,"marketCap":438154667},{"date":"2020-10-02","current":4.933149,"twenty":6.250305,"median":7.971673,"eighty":11.259925,"marketCap":456553075},{"date":"2020-10-09","current":5.360198,"twenty":6.244429,"median":7.94745,"eighty":11.2525,"marketCap":496075580},{"date":"2020-10-16","current":5.26448,"twenty":6.239772,"median":7.932539,"eighty":11.247278,"marketCap":487217087},{"date":"2020-10-23","current":5.271843,"twenty":6.23717,"median":7.912422,"eighty":11.243223,"marketCap":487898510},{"date":"2020-10-30","current":5.338109,"twenty":6.227089,"median":7.896854,"eighty":11.239367,"marketCap":494031312},{"date":"2020-11-06","current":5.459545,"twenty":6.22179,"median":7.88907,"eighty":11.21862,"marketCap":522855188},{"date":"2020-11-13","current":5.670214,"twenty":6.203808,"median":7.87934,"eighty":11.19873,"marketCap":543030764},{"date":"2020-11-20","current":5.877313,"twenty":6.196135,"median":7.85015,"eighty":11.194013,"marketCap":562864382},{"date":"2020-11-27","current":6.170107,"twenty":6.185826,"median":7.85015,"eighty":11.189536,"marketCap":590905013},{"date":"2020-12-04","current":6.109406,"twenty":6.168749,"median":7.838474,"eighty":11.169685,"marketCap":585091712},{"date":"2020-12-11","current":6.416483,"twenty":6.167844,"median":7.834582,"eighty":11.145422,"marketCap":614500179},{"date":"2020-12-18","current":6.230809,"twenty":6.167844,"median":7.828744,"eighty":11.130907,"marketCap":596718315},{"date":"2020-12-24","current":6.048705,"twenty":6.167844,"median":7.82096,"eighty":11.115597,"marketCap":579278410},{"date":"2020-12-31","current":5.934444,"twenty":6.167844,"median":7.817068,"eighty":11.101741,"marketCap":568335725},{"date":"2021-01-08","current":6.062987,"twenty":6.149862,"median":7.795662,"eighty":11.084422,"marketCap":580646246},{"date":"2021-01-15","current":6.216526,"twenty":6.149862,"median":7.785585,"eighty":11.084422,"marketCap":595350479},{"date":"2021-01-22","current":6.705707,"twenty":6.149862,"median":7.780094,"eighty":11.074992,"marketCap":642198851},{"date":"2021-01-29","current":7.180605,"twenty":6.149862,"median":7.776202,"eighty":11.068208,"marketCap":687679388},{"date":"2021-02-05","current":7.284155,"twenty":6.149862,"median":7.768418,"eighty":11.06411,"marketCap":697596196},{"date":"2021-02-12","current":6.934229,"twenty":6.163202,"median":7.760634,"eighty":11.053134,"marketCap":664084222},{"date":"2021-02-19","current":7.112763,"twenty":6.167321,"median":7.75285,"eighty":11.04396,"marketCap":681182168},{"date":"2021-02-26","current":7.202029,"twenty":6.167844,"median":7.741174,"eighty":11.038761,"marketCap":689731141},{"date":"2021-03-05","current":6.896217,"twenty":6.167844,"median":7.718575,"eighty":11.032407,"marketCap":695214499},{"date":"2021-03-12","current":7.842623,"twenty":6.167844,"median":7.698362,"eighty":11.017031,"marketCap":790622686},{"date":"2021-03-19","current":7.720506,"twenty":6.167844,"median":7.718575,"eighty":11.007626,"marketCap":778311953},{"date":"2021-03-26","current":7.411822,"twenty":6.167844,"median":7.69367,"eighty":11.00501,"marketCap":747193153},{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456},{"date":"2025-06-13","current":16.520424,"twenty":4.444767,"median":9.80686,"eighty":15.572999,"marketCap":1905779645},{"date":"2025-06-20","current":16.170677,"twenty":4.440923,"median":9.804164,"eighty":15.627805,"marketCap":1865433127},{"date":"2025-06-27","current":15.57111,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1796267668},{"date":"2025-07-03","current":15.479999,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1785757230},{"date":"2025-07-11","current":15.432974,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1780332488},{"date":"2025-07-18","current":14.992116,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1729475533},{"date":"2025-07-25","current":15.333047,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1768804912},{"date":"2025-08-01","current":15.430035,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1779993442},{"date":"2025-08-08","current":17.700627,"twenty":4.440923,"median":9.82349,"eighty":15.67238,"marketCap":1703526003},{"date":"2025-08-15","current":17.97186,"twenty":4.440923,"median":9.917298,"eighty":15.726991,"marketCap":1729629785},{"date":"2025-08-22","current":17.975383,"twenty":4.440923,"median":9.97212,"eighty":15.765277,"marketCap":1729968795},{"date":"2025-08-29","current":18.669318,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"marketCap":1796753795}],"updateTime":1756799785683},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2564180806","title":"歌礼制药-B(01672)将在第61届欧洲糖尿病研究协会(EASD)年会上报告ASC30 口服小分子GLP-1R激动剂28天多剂量递增研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2564180806","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564180806?lang=zh_cn&edition=fundamental","pubTime":"2025-09-02 17:47","pubTimestamp":1756806434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，将在奥地利维也纳举行的第61届欧洲糖尿病研究协会年会上的简短口头讨论中报告ASC30口服小分子GLP-1受体激动剂28天多剂量递增研究数据。ASC30是一款正在临床研究中的小分子GLP-1R偏向激动剂，具有独特和差异化性质，使得同一小分子同时适用于口服片剂和皮下注射给药成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1340574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01672","BK4144","01477","BK1515","GLP","BK1574","BK4590","BK1161"],"gpt_icon":0},{"id":"2564873378","title":"大行评级｜里昂：上调阿里健康目标价至6.5港元 维持“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2564873378","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564873378?lang=zh_cn&edition=fundamental","pubTime":"2025-09-02 13:35","pubTimestamp":1756791324,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1584","BK1189","BK1615","BK1610","BK1501","BK1617","BK1583","BK1161","BK1589","BK1574","BK1591","BK1142","00241","BK1515","GLP","159992","LU0051755006.USD","06978","BK1571","86618","BK4590","06618","BK1502","BK4144","LU0456827905.SGD","BK1247"],"gpt_icon":0},{"id":"2564805375","title":"减重赛道全球前沿进展跟踪(二)：ORFORGLIPRON领跑全球小分子GLP-1RA赛道 国内管线价值逐渐凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2564805375","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564805375?lang=zh_cn&edition=fundamental","pubTime":"2025-09-02 00:00","pubTimestamp":1756742400,"startTime":"0","endTime":"0","summary":"国产小分子GLP-1RA 通过结构优化与技术改进，疗效有望实现超越，临床开发潜力与商业化价值正持续凸显。药代动力学特征或成为影响小分子GLP-1RA 疗效重要一环药代动力学特征可能是影响小分子GLP-1RA 疗效的重要一环。投资建议小分子GLP-1RA 有望为减重降糖市场提供新的增量空间。国内小分子GLP-1RA 赛道硕果累累，部分管线具备较强出海潜力，相关标的有望受益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902181146a4af790b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902181146a4af790b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2471134796.USD","SGXZ81514606.USD","LU1551013425.SGD","LU1868836757.USD","LU1868837300.USD","BK4533","SG9999014906.USD","SGXZ51526630.SGD","IE00BJJMRZ35.SGD","SG9999017495.SGD","LU0320765992.SGD","SG9999014898.SGD","SG9999015978.USD","LU1366192091.USD","LU0385154629.USD","LU0094547139.USD","LU2552382058.USD","LU1093756168.USD","LU2471134879.HKD","LU0823434583.USD","LU1814569148.SGD","LU2237438978.USD","LU0256863902.USD","BK4534","LU0079474960.USD","LU2602419157.SGD","LU2106854487.HKD","LU0689472784.USD","LU2750360997.AUD","LU0097036916.USD","LU1061106388.HKD","LU0471298694.HKD","LU2236285917.USD","LU1551013342.USD","SGXZ57979304.SGD","LLY","LU2237443549.SGD","LU2237443622.USD","LU2552382132.HKD","LU0096364046.USD","LU1989771016.USD","LU0320765059.SGD","LU0471298777.SGD","LU0203201768.USD","LU1623119135.USD","LU0316494557.USD","LU0323591593.USD","LU2237443465.HKD","GLP","LU0234572021.USD"],"gpt_icon":1},{"id":"2564904118","title":"司美格鲁肽最新临床数据出炉！GLP-1战火延伸至心血管赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2564904118","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564904118?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 16:32","pubTimestamp":1756715572,"startTime":"0","endTime":"0","summary":"【司美格鲁肽最新临床数据出炉！GLP-1战火延伸至心血管赛道】近日，诺和诺德在西班牙马德里举行的2025年欧洲心脏病学会（ESC）年会上公布了STEER真实世界研究的最新数据。该研究基于患者真实用药经历，评估了Wegovy（司美格鲁肽2.4 mg）对比替尔泊肽在超重或肥胖且已确诊心血管疾病但无糖尿病的患者中预防主要不良心血管事件（MACE）的有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509013501076534.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509013501076534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","BK4590","BK4144"],"gpt_icon":0},{"id":"2564807899","title":"在GLP-1（胰高血糖素样肽-1）减肥药的竞争中诺和诺德的司美格鲁肽终于凭借心血管方面的获益扳回一局。9月1日记者从诺和","url":"https://stock-news.laohu8.com/highlight/detail?id=2564807899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564807899?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 14:33","pubTimestamp":1756708413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","MACE","NVO","GLP","LU0154236417.USD","BK4157","LU1093756168.USD","BK4585","LU1093756325.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4183","BK4588","BK4590","BK4144","BK4532","BK4007"],"gpt_icon":0},{"id":"2564862445","title":"礼来终止2项口服GLP-1药二期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2564862445","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564862445?lang=zh_cn&edition=fundamental","pubTime":"2025-09-01 09:40","pubTimestamp":1756690859,"startTime":"0","endTime":"0","summary":"不过，备受关注的口服GLP-1药物orforglipron在三期临床中疗效未达预期。HRS9531是一款恒瑞自主研发的GLP-1/GIP双受体激动剂，该药已在中国开展多项临床试验，累计超过2000名受试者接受了治疗。图：恒瑞医药 部分研发管线歌礼制药口服小分子GLP-1激动剂ASC30在美国Ib期MAD队列2经安慰剂校准后的体重相对基线平均下降6.5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901104047a7084c86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901104047a7084c86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2461242641.AUD","LU2471134523.USD","LU0323591593.USD","SG9999015952.SGD","LU1548497426.USD","BK4516","LU2112291526.USD","SG9999015945.SGD","LU0882574055.USD","LU1061106388.HKD","LU0882574139.USD","LU0234572021.USD","GLP","LU0061475181.USD","LU0109391861.USD","LU1868837300.USD","LU2361044865.SGD","LU1868836591.USD","SG9999001176.SGD","LU2462157665.USD","LLY","LU2237443622.USD","LU1280957306.USD","LU2237443382.USD","Y","LU2089984988.USD","LU2361045086.USD","LU2456880835.USD","LU2552382215.SGD","LU0006306889.USD","LU0417517546.SGD","LU2211815571.USD","LU2468319806.SGD","SGXZ81514606.USD","LU0385154629.USD","LU2552382132.HKD","LU0256863902.USD","01276","LU0640476718.USD","IE00B2B36J28.USD","LU1983299246.USD","SG9999015978.USD","IE00BJLML261.HKD","LU1720051017.SGD","LU1069344957.HKD","LU1868836757.USD","LU2236285917.USD","LU0096364046.USD","LU0094547139.USD","SGXZ99366536.SGD","LU0198837287.USD","LU2750360997.AUD"],"gpt_icon":1},{"id":"2562147775","title":"礼来口服GLP-1药物orforglipron III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2562147775","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562147775?lang=zh_cn&edition=fundamental","pubTime":"2025-08-28 06:04","pubTimestamp":1756332268,"startTime":"0","endTime":"0","summary":"8月26日，礼来公司公布了其在研口服GLP-1受体激动剂orforglipron的III期临床试验ATTAIN-2的积极顶线结果。这项针对合并2型糖尿病的肥胖或超重成人患者的研究表明，orforglipron所有三个剂量组均达到了主要终点和所有关键次要终点。礼来公司表示，随着ATTAIN-2研究的完成，公司已具备向全球监管机构递交orforglipron上市申请所需的全部临床数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828060734a4a359f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828060734a4a359f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0198837287.USD","LU2108987350.USD","BK4134","LU1983299246.USD","LU0094547139.USD","LU1093756325.SGD","LU1989771016.USD","SG9999001176.SGD","LU0106261372.USD","LU2361044865.SGD","LU2417539215.USD","LU1868836757.USD","LU1917777945.USD","Y","LU2471134952.CNY","LU1868837136.USD","SGXZ81514606.USD","LU0456855351.SGD","LU0006306889.USD","LU1023059063.AUD","SG9999015945.SGD","SG9999015978.USD","LU2456880835.USD","LU2237443978.SGD","III","LU1280957306.USD","BK4533","LU1712237335.SGD","LU2357305700.SGD","LU1291159041.SGD","LU0289739699.SGD","LLY","BK4144","LU0823416689.USD","GLP","LU0689472784.USD","LU2237443382.USD","LU1069344957.HKD","LU2237443895.HKD","LU0256863811.USD","BK4581","LU0417517546.SGD","LU2211815571.USD","IE0004445239.USD","LU0203202063.USD","GB00BDT5M118.USD","LU1064131342.USD","LU0109391861.USD","LU0882574139.USD","LU1868837300.USD"],"gpt_icon":1},{"id":"2562719313","title":"谁在网购减重版GLP-1？京东健康：90后购买量排第一，未来电商渠道预计超过七成","url":"https://stock-news.laohu8.com/highlight/detail?id=2562719313","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562719313?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 16:20","pubTimestamp":1756282816,"startTime":"0","endTime":"0","summary":"预计2030年GLP-1市场规模将超千亿，在减重市场，互联网电商渠道正成为新的主流，按照今年整体的预期来测算，会占据超过五成市场份额。在未来趋势中，随着电商化愈发成熟，占比会越来越高，预计超过七成。京东健康的数据显示，今年618期间，其平台GLP-1类用药销量同比增长超过3倍。在备受市场关注的GLP-1赛道方面，增速则更加迅速，可以说是指数级增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508271622569500038f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508271622569500038f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4080","BK4144","BK4231","BK4590","BK4588","O","GLP"],"gpt_icon":0},{"id":"2562079407","title":"映恩生物上半年调整后利润1.46亿元，现金37.47亿元；礼来口服GLP-1一项3期临床成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2562079407","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562079407?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 14:14","pubTimestamp":1756275278,"startTime":"0","endTime":"0","summary":"8月26日，映恩生物公告，上半年总营收12.29亿元，调整后利润1.46亿元，现金总额达到37.47亿元。康诺亚也是在同一天宣布，上半年营收4.99亿元，同比暴增812%，其中包括合作收入3.29亿元。研发支出3.60亿元，同比增长9%。礼来口服GLP-1一项3期临床成功。8月26日，礼来公布了其在研GLP-1受体激动剂orforglipron的3期临床试验ATTAIN-2的积极顶线结果。2）复星医药上半年净利润同比增长38.96%8月26日，复星医药公告，2025年上半年营业收入195.14亿元，净利润17.02亿元，同比增长38.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082714144297641811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082714144297641811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0823416689.USD","LU0266013472.USD","LLY","LU1057294990.SGD","SG9999018865.SGD","LU1061106388.HKD","LU1093756168.USD","LU0238689110.USD","LU1712237335.SGD","LU2746668974.SGD","LU2417539215.USD","LU0006306889.USD","LU2471134796.USD","LU0823434740.USD","LU1551013342.USD","GLP","SG9999013999.USD","LU0203202063.USD","LU2023250504.SGD","Y","LU2468319806.SGD","LU2361044949.HKD","LU2491049909.HKD","IE00BK4W5M84.HKD","LU1366192091.USD","BK4533","LU0689472784.USD","IE0002141913.USD","LU0943347566.SGD","SG9999014898.SGD","LU0820561909.HKD","LU2108987350.USD","LU2361045086.USD","LU1551013425.SGD","LU2237443549.SGD","IE0004445239.USD","LU0079474960.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1814569148.SGD","LU0256863811.USD","LU2552382058.USD","LU1093756325.SGD","LU2089984988.USD","SGXZ31699556.SGD","LU1988902786.USD","LU2237443382.USD","LU0323591593.USD","SG9999014906.USD","LU2112291526.USD","LU2264538146.SGD"],"gpt_icon":1},{"id":"2562734782","title":"Viking Therapeutics股价下跌3.8%竞争对手礼来的GLP - 1药片在糖尿病患者后期研究中助力减轻体重","url":"https://stock-news.laohu8.com/highlight/detail?id=2562734782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562734782?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 21:48","pubTimestamp":1756216116,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2089984988.USD","LU2461242641.AUD","LENZ","LU2264538146.SGD","LU0466842654.USD","LU2237443465.HKD","LU2211815571.USD","LU2750360641.GBP","LU1868836591.USD","SGXZ57979304.SGD","LU0640476718.USD","LU2471134523.USD","BK4533","LU0456855351.SGD","IE0002141913.USD","LU0823434740.USD","LU1720051108.HKD","LU0823434583.USD","LU0114720955.EUR","LU1064131342.USD","LU0096364046.USD","BK4139","LU0820561818.USD","IE0004445239.USD","LU1551013425.SGD","LU1868837300.USD","SGXZ99366536.SGD","LU2324357040.USD","SG9999001176.SGD","LU2237443978.SGD","LU0094547139.USD","LU1280957306.USD","LU2491050154.USD","LU2750360997.AUD","LU0109391861.USD","LU1868836914.USD","LU2106854487.HKD","LLY","LU0058720904.USD","LU0708995401.HKD","LU1366192091.USD","GLP","LU0109394709.USD","LU1988902786.USD","LU2023250504.SGD","LU0122379950.USD","LU2237443622.USD","IE00BFTCPJ56.SGD","LU0823416689.USD","IE00BJLML261.HKD"],"gpt_icon":0},{"id":"2562734322","title":"礼来公司（Eli Lilly）在晚期试验中发现其GLP - 1片剂使2型糖尿病患者体重减轻10.5%该公司股价上涨3.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2562734322","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562734322?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 21:32","pubTimestamp":1756215137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1562215406f683d19f5eb2345c8cc126","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2461242641.AUD","LU2063271972.USD","LU2211815571.USD","LLY","LU2361044949.HKD","LU2237443895.HKD","LU2491050154.USD","LU0256863811.USD","LU1548497426.USD","SGXZ57979304.SGD","LU0094547139.USD","LU2471134952.CNY","LU0820561818.USD","SG9999014880.SGD","GLP","BK4599","LU0889565916.HKD","LU2237443978.SGD","LU0882574055.USD","LU2237443465.HKD","LU0456855351.SGD","LU0289739699.SGD","LU2750360641.GBP","IE00BK4W5L77.USD","LU1023059063.AUD","LU0689472784.USD","LU0786609619.USD","LU0640476718.USD","LU2237443622.USD","LU2491050071.SGD","IE0004445239.USD","IE00B4R5TH58.HKD","IE00BK4W5M84.HKD","LU2491049909.HKD","SG9999014914.USD","LU1623119135.USD","LU1093756325.SGD","LU0432979614.USD","LU2324357040.USD","LU2746668461.USD","BK4516","BK4581","LU0109394709.USD","LU2471134523.USD","LU2552382215.SGD","LU0109391861.USD","LU1267930730.SGD","LU0823434583.USD","LU0079474960.USD","LU1551013425.SGD"],"gpt_icon":0},{"id":"2562851736","title":"礼来公布口服GLP-1RA III期临床结果，肥胖适应症预计今年在美提交","url":"https://stock-news.laohu8.com/highlight/detail?id=2562851736","media":"时代财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562851736?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 20:06","pubTimestamp":1756209973,"startTime":"0","endTime":"0","summary":"本文来源：时代财经8月26日晚间，时代财经获悉，礼来制药公布了每日一次口服小分子GLP-1受体激动剂orforglipron的III期临床试验ATTAIN-2的积极顶线结果。据悉，礼来计划于2025年向美国食品药品管理局提交 orforglipron用于肥胖症治疗的上市许可申请，并于2026年初针对糖尿病治疗启动申报流程。此外，礼来全球高级副总裁、礼来中国药物开发及医学事务中心负责人王莉博士表示，中国已同步加入了orforglipron的全球研发，期待 orforglipron 能早日在中国获批，为中国患者带来新的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082620085194fde36f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082620085194fde36f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SGXZ57979304.SGD","SG9999015952.SGD","BK4144","LU1366192091.USD","LU0203202063.USD","LU1623119135.USD","SGXZ99366536.SGD","LU0882574139.USD","LU2360106947.USD","LU0122379950.USD","LU0256863902.USD","SG9999014906.USD","SG9999018857.SGD","LU0354030438.USD","LU2211815571.USD","LU2461242641.AUD","LU0640476718.USD","LU2237443622.USD","LU0320765992.SGD","LU0820561818.USD","LU1061106388.HKD","LU1069344957.HKD","LU1868837136.USD","LU2471134952.CNY","LU0114720955.EUR","BK4599","LU0672654240.SGD","LU2417539215.USD","SG9999018865.SGD","SGXZ51526630.SGD","LU0058720904.USD","LU2237443895.HKD","LU2746668974.SGD","LU0323591593.USD","LLY","SG9999015945.SGD","III","LU0471298694.HKD","LU0094547139.USD","LU0820561909.HKD","LU2023250504.SGD","LU1232071149.USD","LU1974910355.USD","LU0266013472.USD","IE00BK4W5M84.HKD","GLP","SG9999001176.USD","SGXZ81514606.USD","LU0471298777.SGD","SG9999014880.SGD"],"gpt_icon":1},{"id":"2562735839","title":"礼来公司周二表示其每日服用的减肥药丸在后期试验中帮助肥胖和2型糖尿病患者减轻了体重达到了研究的主要目标为该公司在全球范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2562735839","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562735839?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 19:58","pubTimestamp":1756209527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1562215406f683d19f5eb2345c8cc126","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1804176565.USD","LU1720051017.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU1093756325.SGD","LU2237443465.HKD","LU2237443895.HKD","SGXZ51526630.SGD","LU2106854487.HKD","LU0323591593.USD","LU0820561909.HKD","LU1551013342.USD","LU2108987350.USD","LU1868837136.USD","LU2750360641.GBP","LU1917777945.USD","LU2063271972.USD","LU0079474960.USD","SG9999015986.USD","LU0096364046.USD","SGXZ57979304.SGD","LU0823434740.USD","BK4581","LU2491050154.USD","IE00BK4W5M84.HKD","SG9999014880.SGD","GLP","LU2237443622.USD","LU0234572021.USD","LU0889565916.HKD","LU0471298694.HKD","LU0466842654.USD","BK4144","LU0456855351.SGD","LU0256863811.USD","LU1868837300.USD","NVO","BK4590","LU1057294990.SGD","LU0316494557.USD","LLY","LU0820561818.USD","LU2491049909.HKD","LU0882574055.USD","LU2360106947.USD","LU0320765059.SGD","LU0061475181.USD","LU0097036916.USD","LU0354030511.USD","LU0672654240.SGD"],"gpt_icon":0},{"id":"2562205808","title":"浙商证券：看好国内细分领域布局药企出海BD机遇 关注GLP-1多靶点国内一梯队BD进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2562205808","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562205808?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 11:15","pubTimestamp":1756178124,"startTime":"0","endTime":"0","summary":"浙商证券主要观点如下：一、从MNC的GLP-1布局梳理看BD机会全球GLP-1药物市场由诺和诺德和礼来主导，其他MNC正在加速布局中。同时，上述部分MNC在GLP-1领域的技术路径、新靶点、新适应症等方面的布局仍有较大提升空间，该行看好国内细分领域布局药企出海BD机遇。GLP-1多靶点：全球进度靠前，关注国内一梯队BD进展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0276","BK4144","BK4590","601878","GLP"],"gpt_icon":0},{"id":"2562249689","title":"信达生物小分子GLP-1R激动剂获批临床|亚盛医药Bcl-2抑制剂欧美获批全球注册3期临床|荣昌生物再破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2562249689","media":"中国医药创新促...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562249689?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 16:22","pubTimestamp":1756110166,"startTime":"0","endTime":"0","summary":"信达生物 IBI30328月18日，信达生物申报的1类新药IBI3032获得临床试验默示许可，拟用于成人超重或肥胖患者的长期体重控制。8月21日，泽璟制药宣布，其注射用ZG005、注射用ZGGS18与盐酸吉卡昔替尼片联合用于晚期实体瘤的临床试验获得NMPA批准。8月19日，复宏汉霖宣布与启德医药达成战略合作。8月22日，思路迪医药已与楷拓生物签署战略合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250825162811a6f9f675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250825162811a6f9f675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2561025975","title":"信达生物小分子GLP-1R激动剂在中国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2561025975","media":"药渡","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561025975?lang=zh_cn&edition=fundamental","pubTime":"2025-08-24 07:30","pubTimestamp":1755991846,"startTime":"0","endTime":"0","summary":"中国国家药监局药品审评中心官网近日公示，信达生物申报的1类新药IBI3032获得临床试验默示许可，拟用于成人超重或肥胖患者的长期体重控制。公开资料显示，这是信达生物研发的创新口服小分子GLP-1R激动剂，已经于今年8月初在美国获批IND。作为其自主研发的口服小分子GLP-1药物，IBI3032在临床前动物模型中展现了令人期待的特质，其消除半衰期更长，在相同剂量下的药物暴露水平更高，也展现出了和代谢领域其他靶点小分子更加适合联用的独特潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250824073313a6f7b306&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250824073313a6f7b306&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4590","BK4144","GLP"],"gpt_icon":0},{"id":"2561407331","title":"贝莱德的 Levy-Odom 将领导美洲地区的监管工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2561407331","media":"路透中文","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561407331?lang=zh_cn&edition=fundamental","pubTime":"2025-08-23 03:27","pubTimestamp":1755890824,"startTime":"0","endTime":"0","summary":"贝莱德的 Levy-Odom 将领导美洲地区的监管工作Svea Herbst-Bayliss/Ross Kerber. 路透波士顿8月22日 - 全球最大的资产管理公司贝莱德最近晋升了其管理团队的一名高级成员，作为一系列更广泛的管理层变动的一部分，负责领导公司与美洲数千家企业的互动。贝莱德周五证实，董事总经理 Tanya Levy-Odom 目前在纽约领导贝莱德美洲投资管理团队。今年 7 月，贝莱德在路透看到的一分内部备忘录中表示，罗伊和阿姆拉-巴利奇将共同监督公司的全球监管团队。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nL4T3UE19V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640476718.USD","LU0731783048.USD","LU2592432038.USD","LU0157215616.USD","LU1989771016.USD","IE00BVYPNV92.GBP","BK4534","BK4590","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4504","BLK","LU0070302665.USD","LU0772969993.USD","LU1509826696.USD","IE00B42XCP33.USD","LU1988902786.USD","LU0648001328.SGD","LU1064131342.USD","IE00B3QW5Z07.USD","LU0130102774.USD","BK4144","BK4535","LU2430703251.USD","LU0208291251.USD","LU1481011911.USD","BK4581","LU1670627923.USD","BK4533","LU2430703178.SGD","GLP","LU0742537680.HKD","LU1599440770.SGD","LU1670628061.USD","LU2430703095.HKD","IE00BVYPNW00.USD","LU0731783394.SGD","LU1074936037.SGD","IE00B3PB1722.GBP","LU0980610538.SGD","BK4588","LU1481011671.HKD","LU2264538146.SGD","BK4567","LU0320765489.SGD","LU1366333091.USD","LU2505996681.GBP","IE00BGHQF631.EUR","LU1280957306.USD","LU2505996509.AUD"],"gpt_icon":0},{"id":"2561073394","title":"贝莱德的 Levy-Odom 将领导美洲地区的监管工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2561073394","media":"路透中文","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561073394?lang=zh_cn&edition=fundamental","pubTime":"2025-08-23 03:27","pubTimestamp":1755890824,"startTime":"0","endTime":"0","summary":"贝莱德的 Levy-Odom 将领导美洲地区的监管工作Svea Herbst-Bayliss/Ross Kerber. 路透波士顿8月22日 - 全球最大的资产管理公司贝莱德最近晋升了其管理团队的一名高级成员，作为一系列更广泛的管理层变动的一部分，负责领导公司与美洲数千家企业的互动。贝莱德周五证实，董事总经理 Tanya Levy-Odom 目前在纽约领导贝莱德美洲投资管理团队。今年 7 月，贝莱德在路透看到的一份内部备忘录中表示，罗伊和阿姆拉-巴利奇将共同监督公司的全球监管团队。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nL4S3UE19V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670628061.USD","LU2430703251.USD","BK4533","LU0320765489.SGD","BK4567","LU0157215616.USD","LU1280957306.USD","LU0980610538.SGD","IE00BGHQF631.EUR","BK4504","IE00B3PB1722.GBP","BK4144","LU0640476718.USD","LU2430703178.SGD","LU2505996509.AUD","BK4535","LU1481011911.USD","LU1064131342.USD","LU1670627923.USD","LU0742537680.HKD","LU0731783394.SGD","BK4588","LU1599440770.SGD","BLK","IE00B42XCP33.USD","LU0648001328.SGD","LU0772969993.USD","LU0208291251.USD","IE00BVYPNW00.USD","LU0731783048.USD","LU0070302665.USD","IE00BVYPNV92.GBP","LU2505996681.GBP","LU2264538146.SGD","IE00B64PRP62.GBP","LU2430703095.HKD","LU1989771016.USD","BK4590","LU0130102774.USD","LU1988902786.USD","LU1074936037.SGD","GLP","BK4534","IE00B3QW5Z07.USD","BK4581","LU1366333091.USD","LU1509826696.USD","LU2592432038.USD","IE00BGHQF748.EUR","LU1481011671.HKD"],"gpt_icon":0},{"id":"2561682094","title":"研报掘金丨开源证券：华东医药创新药收入快速增长，维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2561682094","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561682094?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 17:22","pubTimestamp":1755768169,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","BK0188","000963","LU1969619763.USD","BK0132","BK0187","BK0183","BK4590","BK4144","BK0209","BK0196","BK1574","159992","PD","LU1169589451.USD","GLP","161027","BK4231","BK1515","09939","ADC","LU2328871848.SGD","BK4080","159938","06978","BK4023","LU1169590202.USD","BK0175"],"gpt_icon":0},{"id":"2561438632","title":"总数跌破70万家，零售药店上演“鱿鱼游戏”！有门店下场做药妆、开卖GLP-1减肥药","url":"https://stock-news.laohu8.com/highlight/detail?id=2561438632","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561438632?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 07:39","pubTimestamp":1755733159,"startTime":"0","endTime":"0","summary":"零售药品市场大洗牌，药店总量跌破70万家零售药品市场正在经历新一轮变革，亟待重启。其中，2024年第一季度和第二季度零售药店市场规模分别为1328亿元和1257亿元，同比分别下跌4.0%和3.8%；2024年下半年降幅缩窄，其中第三季度零售药店市场规模同比增长1.3%。2024年第四季度、2025年第一季度，药店总量跌破70万家，从而进入到真正的负增长阶段。药店下场做护肤品“代理商”，GLP-1强势入局在这种情况下，零售药店亟需在关店之外找到“第二增长曲线”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/21073952577500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4590","GLP","BK4144"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":149,"code":"91000000","status":"200"}]}}